Direct oral anticoagulants versus vitamin K antagonists in patients with antiphospholipid syndrome: systematic review and meta-analysis

BACKGROUND: Despite vitamin K antagonists (VKA) being the gold standard in the prevention of thromboembolic events in antiphospholipid syndrome (APS), non-vitamin K antagonists oral anticoagulants/direct oral anticoagulants (DOACs) have been used off-label. OBJECTIVE: We aimed to perform a systemati...

Descripción completa

Detalles Bibliográficos
Autores principales: Koval, Nazariy, Alves, Mariana, Plácido, Rui, Almeida, Ana G, Fonseca, João Eurico, Ferreira, Joaquim J, Pinto, Fausto J, Caldeira, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Autoimmunity
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276293/
https://www.ncbi.nlm.nih.gov/pubmed/34253684
http://dx.doi.org/10.1136/rmdopen-2021-001678

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276293/
https://www.ncbi.nlm.nih.gov/pubmed/34253684
http://dx.doi.org/10.1136/rmdopen-2021-001678

Ejemplares similares